Patient Investigator, Canada.
Adult Metabolic Diseases Clinic, Vancouver General Hospital, Canada; Division of Neurology, Vancouver General Hospital, Canada.
Mitochondrion. 2020 May;52:183-189. doi: 10.1016/j.mito.2020.03.009. Epub 2020 Mar 29.
A 56-year-old female, diagnosed as a carrier of the mitochondrial DNA mutation (MTTK c.8344A > G) associated with the MERRF (myoclonic epilepsy with ragged red fibers) syndrome, presented with a relatively uncommon but well-known phenotypic manifestation: severe multiple symmetric lipomatosis (MSL). After surgical resection of three kilograms of upper mid-back lipomatous tissue, the patient experienced a significant decline in her functional capacity and quality of life, which ultimately resulted in her placement on long-term disability.
Dissatisfied with the available treatment options centered on additional resection surgeries, given the high probability of lipoma regrowth, the patient independently researched and applied alternative therapies that centred on a carbohydrate-restricted diet and a supervised exercise program.
The cumulative effect of her lifestyle interventions resulted in the reversal of her MSL and her previously low quality of life. She met all her personal goals by the one-year mark, including reduced size of the residual post-surgical lipomas, markedly enhanced exercise tolerance, and return to work. She continues to maintain her interventions and to experience positive outcomes at the two-year mark.
This case report documents the timing and nature of lifestyle interventions in relation to the reversal in growth pattern of her previously expanding and debilitating lipomas. The profound nature of the apparent benefit on lipoma growth demonstrates the intervention's potential as a new feasible non-surgical therapy for mitochondrial-disease-associated MSL, and justifies its systematic study. We also describe how this case has inspired the care team to re-examine its approach to involved patients.
一位 56 岁的女性,被诊断为与 MERRF(肌阵挛性癫痫伴破碎红纤维)综合征相关的线粒体 DNA 突变(MTTK c.8344A>G)携带者,表现出一种相对不常见但众所周知的表型表现:严重多发性对称性脂肪瘤病(MSL)。在切除三公斤上背部脂肪瘤组织后,患者的功能能力和生活质量显著下降,最终导致她长期残疾。
由于脂肪瘤再次生长的可能性很高,患者对以额外切除手术为中心的现有治疗方案不满意,因此独立研究并应用了以碳水化合物限制饮食和监督运动计划为中心的替代疗法。
她的生活方式干预的累积效应导致她的 MSL 逆转和以前较低的生活质量得到改善。到一年时,她达到了所有个人目标,包括残余手术后脂肪瘤的大小减小、运动耐量明显提高和恢复工作。她继续维持她的干预措施,并在两年时仍获得积极的结果。
本病例报告记录了生活方式干预与她先前不断扩大和使衰弱的脂肪瘤生长模式逆转之间的时间和性质。脂肪瘤生长明显受益的程度表明,该干预措施作为一种针对与线粒体疾病相关的 MSL 的新可行非手术治疗方法具有潜力,并证明有必要对其进行系统研究。我们还描述了该病例如何启发护理团队重新审视其对受累患者的治疗方法。